UW Daily: Turning the tide on HIV

By Chelsea Gish

The ASPIRE trial and The Ring Study, two large scale clinical trials, have found that microbicides can safely reduce the risk of new HIV infections in women.

A microbicide is any compound capable of destroying microbes and infectious agents. Recently, this method of prevention has become particularly relevant in reducing the transmission of HIV when applied to the vaginal or rectal region as a topical gel.

...

NewsBeat: Microbicide Reduces Women's HIV Risk in Large-Scale Trial

By Lisa Rossi

Two large clinical trials have found that a microbicide prevention method can safely help reduce new HIV infections in women.

Results of the ASPIRE trial, which enrolled more than 2,600 women in Africa, were announced today at the Conference on Retroviruses and Opportunistic Infections in Boston. The results also will be published online in the New England Journal of Medicine.

Pages